188 related articles for article (PubMed ID: 29079955)
21. Presentation, management, and outcome of newly diagnosed glioblastoma in elderly patients.
Tanaka S; Meyer FB; Buckner JC; Uhm JH; Yan ES; Parney IF
J Neurosurg; 2013 Apr; 118(4):786-98. PubMed ID: 23176331
[TBL] [Abstract][Full Text] [Related]
22. Prognosis of patients with multifocal glioblastoma: a case-control study.
Patil CG; Yi A; Elramsisy A; Hu J; Mukherjee D; Irvin DK; Yu JS; Bannykh SI; Black KL; Nuño M
J Neurosurg; 2012 Oct; 117(4):705-11. PubMed ID: 22920963
[TBL] [Abstract][Full Text] [Related]
23. Progress Toward Long-Term Survivors of Glioblastoma.
Cantrell JN; Waddle MR; Rotman M; Peterson JL; Ruiz-Garcia H; Heckman MG; Quiñones-Hinojosa A; Rosenfeld SS; Brown PD; Trifiletti DM
Mayo Clin Proc; 2019 Jul; 94(7):1278-1286. PubMed ID: 31230743
[TBL] [Abstract][Full Text] [Related]
24. The cohort of long-term survivors at the German childhood cancer registry.
Debling D; Spix C; Blettner M; Michaelis J; Kaatsch P
Klin Padiatr; 2008; 220(6):371-7. PubMed ID: 18949673
[TBL] [Abstract][Full Text] [Related]
25. Prognostic factors for glioblastoma patients--a clinical population-based study.
Fekete B; Werlenius K; Örndal C; Rydenhag B
Acta Neurol Scand; 2016 Jun; 133(6):434-41. PubMed ID: 26358197
[TBL] [Abstract][Full Text] [Related]
26. Developing an Algorithm for Optimizing Care of Elderly Patients With Glioblastoma.
Flanigan PM; Jahangiri A; Kuang R; Truong A; Choi S; Chou A; Molinaro AM; McDermott MW; Berger MS; Aghi MK
Neurosurgery; 2018 Jan; 82(1):64-75. PubMed ID: 28475720
[TBL] [Abstract][Full Text] [Related]
27. Metronomic chemotherapy with daily low-dose temozolomide and celecoxib in elderly patients with newly diagnosed glioblastoma multiforme: a retrospective analysis.
Welzel G; Gehweiler J; Brehmer S; Appelt JU; von Deimling A; Seiz-Rosenhagen M; Schmiedek P; Wenz F; Giordano FA
J Neurooncol; 2015 Sep; 124(2):265-73. PubMed ID: 26045360
[TBL] [Abstract][Full Text] [Related]
28. Role of surgical resection in recurrent glioblastoma: prognostic factors and outcome evaluation in an observational study.
Pessina F; Navarria P; Cozzi L; Tomatis S; Riva M; Ascolese AM; Santoro A; Simonelli M; Bello L; Scorsetti M
J Neurooncol; 2017 Jan; 131(2):377-384. PubMed ID: 27826681
[TBL] [Abstract][Full Text] [Related]
29. Differential Predictors and Clinical Implications Associated With Long-Term Survivors in IDH Wildtype and Mutant Glioblastoma.
Jiang H; Yu K; Cui Y; Ren X; Li M; Zhang G; Yang C; Zhao X; Zhu Q; Lin S
Front Oncol; 2021; 11():632663. PubMed ID: 34055603
[TBL] [Abstract][Full Text] [Related]
30. Survival improvements with adjuvant therapy in patients with glioblastoma.
Jayamanne D; Wheeler H; Cook R; Teo C; Brazier D; Schembri G; Kastelan M; Guo L; Back MF
ANZ J Surg; 2018 Mar; 88(3):196-201. PubMed ID: 28922698
[TBL] [Abstract][Full Text] [Related]
31. Survival benefit of levetiracetam in patients treated with concomitant chemoradiotherapy and adjuvant chemotherapy with temozolomide for glioblastoma multiforme.
Kim YH; Kim T; Joo JD; Han JH; Kim YJ; Kim IA; Yun CH; Kim CY
Cancer; 2015 Sep; 121(17):2926-32. PubMed ID: 25975354
[TBL] [Abstract][Full Text] [Related]
32. Post-operative management of primary glioblastoma multiforme in patients over 60 years of age.
Daróczi B; Szántó E; Tóth J; Barzó P; Bognár L; Bakó G; Szántó J; Mózes P; Hideghéty K
Ideggyogy Sz; 2013 Nov; 66(11-12):391-8. PubMed ID: 24555238
[TBL] [Abstract][Full Text] [Related]
33. Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.
Niranjan A; Kano H; Iyer A; Kondziolka D; Flickinger JC; Lunsford LD
J Neurosurg; 2015 Apr; 122(4):757-65. PubMed ID: 25594327
[TBL] [Abstract][Full Text] [Related]
34. Impact of waiting time after surgery and overall time of postoperative radiochemotherapy on treatment outcome in glioblastoma multiforme.
Seidlitz A; Siepmann T; Löck S; Juratli T; Baumann M; Krause M
Radiat Oncol; 2015 Aug; 10():172. PubMed ID: 26276734
[TBL] [Abstract][Full Text] [Related]
35. Survival outcomes of giant cell glioblastoma: institutional experience in the management of 20 patients.
Oh T; Rutkowski MJ; Safaee M; Sun MZ; Sayegh ET; Bloch O; Tihan T; Parsa AT
J Clin Neurosci; 2014 Dec; 21(12):2129-34. PubMed ID: 25037316
[TBL] [Abstract][Full Text] [Related]
36. [The phenomenon of long-term survival in glioblastoma patients. Part I: the role of clinical and demographic factors and an IDH1 mutation (R 132 H)].
Goryaynov SA; Gol'dberg MF; Golanov AV; Zolotova SV; Shishkina LV; Ryzhova MV; Pitskhelauri DI; Zhukov VY; Usachev DY; Belyaev AY; Kondrashov AV; Shurkhay VA; Potapov AA
Zh Vopr Neirokhir Im N N Burdenko; 2017; 81(3):5-16. PubMed ID: 28665384
[TBL] [Abstract][Full Text] [Related]
37. Long-term survivors after pancreatectomy for cancer: the TNM classification is outdated.
Jouffret L; Turrini O; Ewald J; Moutardier V; Iovanna JL; Delpero JR
ANZ J Surg; 2015 Nov; 85(11):860-4. PubMed ID: 26331377
[TBL] [Abstract][Full Text] [Related]
38. Survival Outcomes of Elderly Patients With Glioblastoma Multiforme in Their 75th Year or Older Treated With Adjuvant Therapy.
Harris G; Jayamanne D; Wheeler H; Gzell C; Kastelan M; Schembri G; Brazier D; Cook R; Parkinson J; Khasraw M; Louw S; Back M
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):802-810. PubMed ID: 28602411
[TBL] [Abstract][Full Text] [Related]
39. Disparities in receipt of modern concurrent chemoradiotherapy in glioblastoma.
Rhome R; Fisher R; Hormigo A; Parikh RR
J Neurooncol; 2016 Jun; 128(2):241-50. PubMed ID: 26970981
[TBL] [Abstract][Full Text] [Related]
40. Multiple craniotomies in the management of multifocal and multicentric glioblastoma. Clinical article.
Hassaneen W; Levine NB; Suki D; Salaskar AL; de Moura Lima A; McCutcheon IE; Prabhu SS; Lang FF; DeMonte F; Rao G; Weinberg JS; Wildrick DM; Aldape KD; Sawaya R
J Neurosurg; 2011 Mar; 114(3):576-84. PubMed ID: 20690813
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
